Clinical Trials at University of California Davis Comprehensive Cancer Center

As of August 2026, 90 paid clinical trials are recruiting at University of California Davis Comprehensive Cancer Center, located at 2315 STOCKTON BLVD, SACRAMENTO, CA 95817-2201, phone (916) 734-0855 in Sacramento, California. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: August 13, 2026.

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

91 clinical trials at University of California Davis Comprehensive Cancer Center

·Clear filters·

Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma

for Diffuse Large B-Cell Lymphoma

Sites in Sacramento, Los Angeles +1 more location

Sponsor: Jonsson Comprehensive Cancer Center

Sex: All·Age: 18 - 70

Code: NCT05256641·Phase 1, Phase 2·Recruiting·Listed Feb 2022

Apply to this trial

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

for Breast Cancer

1 location in Sacramento

Sponsor: University of California, Davis

Sex: All·Age: 18+

Code: NCT06268665·Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

for Glioblastoma

1 location in Sacramento

Sponsor: University of California, Davis

Sex: All·Age: 18+

Code: NCT07145112·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities

for Multiple Myeloma

1 location in Sacramento

Sponsor: University of California, Davis

Sex: All·Age: 21+

Code: NCT04314752·Recruiting·Listed Mar 2020

Apply to this trial

Azacitidine or Decitabine With Venetoclax for Acute Myeloid Leukemia With Prior Hypomethylating Agent Failure

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in Sacramento, Clovis +2 more locations

Sponsor: Brian Jonas

Sex: All·Age: 18+

Code: NCT04905810·Phase 2·Recruiting·Listed May 2021

Apply to this trial

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

for Accelerated Phase Myeloproliferative Neoplasm

Drug: Iadademstat

Sites in Sacramento, Palo Alto +29 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06661915·Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

for Endometrial Carcinoma

Sites in Sacramento, Roseville +323 more locations

Sponsor: National Cancer Institute (NCI)

Sex: Female·Age: 18+

Code: NCT05256225·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene

for Metastatic Malignant Solid Neoplasm

Sites in Sacramento, Lancaster +16 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT05372614·Phase 1·Recruiting·Listed May 2022

Apply to this trial

Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)

for Hemophagocytic Lymphohistiocytoses

Drug: Ruxolitinib

Sites in Sacramento, San Francisco +2 more locations

Sponsor: Jerry Lee, MD, MSc, MPhil

Sex: All·Age: 18+

Code: NCT06160791·Phase 2·Recruiting·Listed Dec 2023

Apply to this trial

Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma

for Recurrent Diffuse Large B-Cell Lymphoma

Drug: Rituximab

1 location in Sacramento

Sponsor: University of California, Davis

Sex: All·Age: 18+

Code: NCT05052528·Phase 1·Recruiting·Listed Sep 2021

Apply to this trial